Expanding the spectrum of Gorham Stout disease exploring a single center pediatric case series

I Rana1, P S Buonuomo1, G Mastrogiorgio1

  • 1Rare Diseases and Medical Genetics, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Lymphology
|January 24, 2022
PubMed

Insights

Gorham-Stout Disease (GSD) requires prompt diagnosis and multidisciplinary care to prevent severe complications. Early identification and treatment are crucial for managing this rare bone disorder.

Area of Science:

  • Medicine
  • Orthopedics
  • Rare Diseases

Background:

  • Gorham-Stout Disease (GSD), or vanishing bone disease, is an ultrarare condition causing progressive osteolysis and bone loss.
  • GSD is characterized by intraosseous lymphatic vessel proliferation and affects all ages, predominantly children and young adults.
  • Approximately 300 cases of GSD have been documented globally.

Purpose of the Study:

  • To retrospectively review internal patient data on Gorham-Stout Disease.
  • To propose a diagnostic-therapeutic protocol for earlier GSD diagnosis and treatment.
  • To enhance understanding of GSD management strategies.

Main Methods:

  • Retrospective case-series review of internal patient datasets.
  • Identification and analysis of pediatric Gorham-Stout Disease cases.
  • Documentation of diagnostic and treatment pathways for GSD patients.

Main Results:

  • Nine pediatric cases of Gorham-Stout Disease were identified and analyzed.
  • Delayed diagnosis significantly correlated with increased patient morbidity.
  • Multidisciplinary care was identified as essential for effective GSD management.

Conclusions:

  • Early diagnosis of Gorham-Stout Disease is critical to mitigate morbidity.
  • A multidisciplinary approach is paramount for optimal GSD patient management.
  • Physicians must maintain awareness of GSD clinical features to prevent fatal outcomes from neglected cases.